COMBINATION COMPRISING AN HMG-COA REDUCTASE INHIBITOR AND AN INSULIN SECRETOR ENHANCER OR AN INSULIN SENSITIZER

摘要

The present invention relates to a combination, especially a pharmaceutical composition, comprising as active ingredients (i) a HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof; (ii) (a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof or (b) an insulin sensitizer or a pharmaceutically acceptable salt thereof; and, in case of a pharmaceutical composition, a pharmaceutically acceptable carrier.